A detailed history of Harbor Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Harbor Advisors LLC holds 5,000 shares of BMY stock, worth $293,700. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,000
Previous 5,000 -0.0%
Holding current value
$293,700
Previous $207,000 24.64%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $246,050 - $320,950
5,000 New
5,000 $321,000
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $248,160 - $295,900
-5,500 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
5,500
5,500 $306,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Harbor Advisors LLC Portfolio

Follow Harbor Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Advisors LLC with notifications on news.